All MTX articles
-
NewsScientists develop novel combination therapy for treating vancomycin-resistant bacterial infections
Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the vancomycin.
